- Home
- PRPH vs ALLR Comparison
PRPH vs ALLR Comparison
Compare PRPH & ALLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRPH
- ALLR
- Stock Information
- Founded
- PRPH 1989
- ALLR 2004
- Country
- PRPH United States
- ALLR United States
- Employees
- PRPH N/A
- ALLR N/A
- Industry
- PRPH Biotechnology: Pharmaceutical Preparations
- ALLR Biotechnology: Pharmaceutical Preparations
- Sector
- PRPH Health Care
- ALLR Health Care
- Exchange
- PRPH Nasdaq
- ALLR Nasdaq
- Market Cap
- PRPH 17.9M
- ALLR 15.8M
- IPO Year
- PRPH 1997
- ALLR N/A
- Fundamental
- Price
- PRPH N/A
- ALLR $1.70
- Analyst Decision
- PRPH
- ALLR Strong Buy
- Analyst Count
- PRPH 0
- ALLR 1
- Target Price
- PRPH N/A
- ALLR $9.25
- AVG Volume (30 Days)
- PRPH 2.4M
- ALLR 620.1K
- Earning Date
- PRPH 11-12-2025
- ALLR 11-13-2025
- Dividend Yield
- PRPH N/A
- ALLR N/A
- EPS Growth
- PRPH N/A
- ALLR N/A
- EPS
- PRPH N/A
- ALLR N/A
- Revenue
- PRPH $5,588,000.00
- ALLR N/A
- Revenue This Year
- PRPH $221.82
- ALLR N/A
- Revenue Next Year
- PRPH N/A
- ALLR N/A
- P/E Ratio
- PRPH N/A
- ALLR N/A
- Revenue Growth
- PRPH N/A
- ALLR N/A
- 52 Week Low
- PRPH $0.22
- ALLR $0.61
- 52 Week High
- PRPH $2.50
- ALLR $2.35
- Technical
- Relative Strength Index (RSI)
- PRPH 78.99
- ALLR 58.30
- Support Level
- PRPH $0.40
- ALLR $1.54
- Resistance Level
- PRPH $0.67
- ALLR $1.77
- Average True Range (ATR)
- PRPH 0.05
- ALLR 0.12
- MACD
- PRPH 0.02
- ALLR -0.01
- Stochastic Oscillator
- PRPH 78.72
- ALLR 66.67
About PRPH ProPhase Labs Inc. (DE)
ProPhase Labs Inc is a diversified company offering various services, including diagnostic testing, genomics testing, and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers, and government organizations. The Consumer Products segment is engaged in the research, development, manufacture, distribution, marketing, and sale of OTC consumer healthcare products and dietary supplements in the United States. It also provides personal genomics products and services.
About ALLR Allarity Therapeutics Inc.
Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.